Added to YB: 2026-04-15
Pitch date: 2026-04-13
NVNO [neutral]
enVVeno Medical Corporation
+2.52%
current return
Author Info
Liquidation stocks is focused on liquidation and wind downs of listed stocks. I cover USA, Canada, UK, Europe, Australia, NZL, Japan, Hong Kong and other countries. Sign up for the newsletter.
Company Info
enVVeno Medical Corporation, a clinical-stage medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease.
Market Cap
$7.2M
Pitch Price
$10.73
Price Target
37.00 (+236%)
Dividend
N/A
EV/EBITDA
1.02
P/E
-0.33
EV/Sales
N/A
Sector
Health Care Equipment and Supplies
Category
special_situation
Liquidations Newsletter - Potential Liquidations: enVVeno Medical Corporation
NVNO (liquidation overview): Medical device co developing artificial vein valves. NorthStrive (5% holder) calls for liquidation or RTO after FDA 'Not Approvable' letter (stock -70%). Board rejected prior suggestions. NSC estimates $37/share liquidation value vs current price.
Read full article (1 min)